COPD (NR-E)
Initiated at the University of Copenhagen and funded by a grant from the Danish government, this clinical trial evaluated the effect of Elysium’s proprietary nicotinamide riboside (NR-E) on clinical outcomes in elderly patients with COPD. The study results, which are in pre-print, showed that NR-E supplementation supported a healthy inflammation response in the lungs. ClinicalTrials.gov Identifier: NCT04990869